查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1225589

全球中風管理市場-增長、未來展望、競爭分析 (2023-2031)

Stroke Management Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

不斷上升的中風診斷率、不斷進步的技術進步正在推動市場的增長。 然而，高昂的治療成本和政府批准新的先進診斷技術的嚴格政策可能會限制該市場的增長。

本報告對全球中風管理市場進行研究和分析，提供包括市場動態、市場分析和公司概況在內的系統信息。

內容

第一章前言

  • 報告說明
    • 報告的目的
    • 目標
    • 主要產品
  • 市場細分
  • 調查方法
    • 第一階段 - 第二次調查
    • 第二階段 - 第一項研究
    • 第三階段 - 專家評審
    • 假設
    • 採用的方法

第 2 章執行摘要

  • 市場概況：全球中風管理市場
  • 全球中風管理市場（百萬美元）（2022 年）：按產品分類
  • 全球中風管理市場（百萬美元）（2022 年）：按應用分類
  • 全球中風管理市場（百萬美元）（2022 年）：按地區
  • 有吸引力的投資建議 (2022)：按地區

第 3 章中風管理市場：競爭分析

  • 領先的中風管理市場供應商的市場定位
  • 供應商在中風管理市場中採用的策略
  • 主要行業戰略
  • 2022 年和 2031 年層次結構分析比較

第 4 章中風管理市場：宏觀分析和市場動態

  • 介紹
  • 世界中風管理市場價值（百萬美元）（2021-2031 年）
  • 市場動態
    • 市場驅動力
    • 市場製約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章中風管理市場，百萬美元 (2021-2031)：按產品分類

  • 市場概覽
  • 增長和收益分析：2022 年和 2031 年的比較
  • 市場細分
    • 診斷
    • 治療

第 6 章中風管理市場，百萬美元 (2021-2031)：按應用

  • 市場概覽
  • 增長和收益分析：2022 年和 2031 年的比較
  • 市場細分
    • 缺血性中風
    • 出血性中風

第 7 章。北美中風管理市場，百萬美元 (2021-2031)

第 8 章英國和歐盟中風管理市場，百萬美元 (2021-2031)

第 9 章亞太中風管理市場，百萬美元 (2021-2031)

第 10 章拉丁美洲中風管理市場，百萬美元 (2021-2031)

第 11 章中東和非洲中風管理市場，百萬美元 (2021-2031)

第12章公司簡介

  • B Braun Melsungen AG
  • Abbott Laboratories
  • Boston Scientific Corp,
  • Medtronic Plc.
  • Bristol-Myers Squibb
  • Cardinal Health
  • Siemens Healthcare
  • GE Healthcare
  • Merck & Company
  • GlaxoSmithKline Plc.
  • 他
Product Code: 138176-01-23

Stroke is predominantly observed among the geriatric population and is globally considered as a major cause of death. The rise in adoption of unhealthy lifestyle patterns, alcohol and smoking addiction has collectively contributed to the rise in prevalence of stroke. As per the America Medical Association, around 40% of geriatric population (aged 55 and above) of U.S. suffer from stroke. The World Health Organization estimates around 17 million deaths due to stroke annually. According to the Centers for Disease Control and Prevention, around 0.7 million individuals in the U.S. suffer from stroke each year. The rise in prevalence of stroke fuels the overall market growth. The stroke management market is analysed by segmenting the market into type of products, application and geography. The products are further classified into diagnostic and therapeutic products.

The growing awareness among individuals and healthcare professionals play an important role in the growth of this market. The rise in awareness has led to the increase in diagnosis rate of stroke, thus accounted for its maximum market share in 2022. With the rise in technological advancements and with patients considering preventive diagnosis, the diagnostic segment would also attain fastest CAGR during the forecast period. The availability of suitable treatment guidelines ensures appropriate treatment thus catalysing the overall stroke management market. The American Heart Association collaborated with the Heart Rhythm Society, the American Academy of Family Physicians and the International Society for Heart & Lung Transplantation to develop guidelines that would aid physicians in appropriate treatment of heart failures. These guidelines provide a foundation for appropriate cardiovascular care. However, high treatment cost and stringent government policies to approve new an advanced diagnostic technologies could intervene with the growth of this market.

Of the various geographical regions analysed, North America held the largest market share in 2022. Asia Pacific projected to grow with fastest CAGR during the forecast period from 2023 to 2031. The North American market growth is predominantly driven by the rise in prevalence of chronic diseases leading to cardiovascular risks, increased disposable income, rise in healthcare expenditure and the constant investments in research and development.

The global stroke management market comprises market players namely B Braun Melsungen AG, Abbott Laboratories, Boston Scientific Corp, Medtronic Plc., Bristol-Myers Squibb, Cardinal Health, , Siemens Healthcare, GE Healthcare, Merck & Company and GlaxoSmithKline Plc.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Stroke Management market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Stroke Management market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

Diagnostics

Computed Tomography Scan (CT Scan)

Magnetic Resonance Imaging (MRI)

Carotid Ultrasound

Cerebral Angiography

Electrocardiography

Echocardiography

Other diagnostics

Therapeutics

Tissue Plasminogen Activator

Anticoagulant

Antiplatelet

Antihypertensive

Application

Ischemic Stroke

Haemorrhagic Stroke

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2021-2022; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Stroke Management market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Stroke Management market?

Which is the largest regional market for Stroke Management market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Stroke Management market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Stroke Management market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Stroke Management Market
  • 2.2. Global Stroke Management Market, By Product, 2022 (US$ Million)
  • 2.3. Global Stroke Management Market, By Application, 2022 (US$ Million)
  • 2.4. Global Stroke Management Market, By Geography, 2022 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2022

3. Stroke Management Market: Competitive Analysis

  • 3.1. Market Positioning of Key Stroke Management Market Vendors
  • 3.2. Strategies Adopted by Stroke Management Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Stroke Management Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Stroke Management Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Stroke Management Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Diagnostics
      • 5.3.1.1. Computed Tomography Scan (CT Scan)
      • 5.3.1.2. Magnetic Resonance Imaging (MRI)
      • 5.3.1.3. Carotid Ultrasound
      • 5.3.1.4. Cerebral Angiography
      • 5.3.1.5. Electrocardiography
      • 5.3.1.6. Echocardiography
      • 5.3.1.7. Other diagnostics
    • 5.3.2. Therapeutics
      • 5.3.2.1. Tissue Plasminogen Activator
      • 5.3.2.2. Anticoagulant
      • 5.3.2.3. Antiplatelet
      • 5.3.2.4. Antihypertensive

6. Stroke Management Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Ischemic Stroke
    • 6.3.2. Haemorrhagic Stroke

7. North America Stroke Management Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 7.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 7.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 7.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

8. UK and European Union Stroke Management Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 8.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 8.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.4.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.5.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 8.4.1.6.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

9. Asia Pacific Stroke Management Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 9.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 9.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.4.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.5.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 9.4.1.6.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

10. Latin America Stroke Management Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 10.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 10.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 10.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

11. Middle East and Africa Stroke Management Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Stroke Management Market: By Product, 2021-2031, USD (Million)
  • 11.3. Stroke Management Market: By Application, 2021-2031, USD (Million)
  • 11.4.Stroke Management Market: By Region, 2021-2031, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.1.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.2.1. Stroke Management Market: By Application, 2021-2031, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Stroke Management Market: By Product, 2021-2031, USD (Million)
        • 11.4.1.3.1. Stroke Management Market: By Application, 2021-2031, USD (Million)

12. Company Profile

  • 12.1. B Braun Melsungen AG
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Abbott Laboratories
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Boston Scientific Corp,
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Medtronic Plc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Bristol-Myers Squibb
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Cardinal Health
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Siemens Healthcare
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. GE Healthcare
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Merck & Company
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. GlaxoSmithKline Plc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Others
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 3 Global Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 4 Global Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 5 North America Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 6 North America Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 7 North America Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 8 North America Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 10 U.S. Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 11 U.S. Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 12 U.S. Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 13 Canada Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 14 Canada Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 15 Canada Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 16 Canada Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 17 Rest of North America Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 18 Rest of North America Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 19 Rest of North America Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 20 Rest of North America Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK and European Union Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 22 UK and European Union Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 23 UK and European Union Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 24 UK and European Union Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 25 UK Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 26 UK Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 27 UK Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 28 UK Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 29 Germany Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 30 Germany Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 31 Germany Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 32 Germany Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 33 Spain Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 34 Spain Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 35 Spain Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 36 Spain Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 37 Italy Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 38 Italy Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 39 Italy Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 40 Italy Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 41 France Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 42 France Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 43 France Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 44 France Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Rest of Europe Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 46 Rest of Europe Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 47 Rest of Europe Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 48 Rest of Europe Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 49 Asia Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Asia Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 51 Asia Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 52 Asia Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 53 China Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 54 China Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 55 China Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 56 China Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Japan Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 58 Japan Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 59 Japan Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 60 Japan Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 61 India Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 62 India Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 63 India Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 64 India Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 65 Australia Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 66 Australia Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 67 Australia Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 68 Australia Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 69 South Korea Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 70 South Korea Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 71 South Korea Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 72 South Korea Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 73 Latin America Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Latin America Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 75 Latin America Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 76 Latin America Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 77 Brazil Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 78 Brazil Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 79 Brazil Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 80 Brazil Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 81 Mexico Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 82 Mexico Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 83 Mexico Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 84 Mexico Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 85 Rest of Latin America Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 86 Rest of Latin America Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 87 Rest of Latin America Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 88 Rest of Latin America Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 89 Middle East and Africa Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 90 Middle East and Africa Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 91 Middle East and Africa Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 92 Middle East and Africa Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 93 GCC Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 94 GCC Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 95 GCC Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 96 GCC Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 97 Africa Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 98 Africa Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 99 Africa Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 100 Africa Stroke Management Market By Application, 2021-2031, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Stroke Management Market By Product, 2021-2031, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Stroke Management Market By Diagnostics, 2021-2031, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Stroke Management Market By Therapeutics, 2021-2031, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Stroke Management Market By Application, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Stroke Management Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Stroke Management Market: Quality Assurance
  • FIG. 5 Global Stroke Management Market, By Product, 2022
  • FIG. 6 Global Stroke Management Market, By Application, 2022
  • FIG. 7 Global Stroke Management Market, By Geography, 2022
  • FIG. 8 Market Geographical Opportunity Matrix - Global Stroke Management Market, 2022
  • FIG. 9 Market Positioning of Key Stroke Management Market Players, 2022
  • FIG. 10 Global Stroke Management Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 11 Global Stroke Management Market, By Product, 2022 Vs 2031, %
  • FIG. 12 Global Stroke Management Market, By Application, 2022 Vs 2031, %
  • FIG. 13 U.S. Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 14 Canada Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 15 Rest of North America Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 16 UK Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 17 Germany Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 18 Spain Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 19 Italy Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 20 France Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 21 Rest of Europe Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 22 China Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 23 Japan Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 24 India Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 25 Australia Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 26 South Korea Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 27 Rest of Asia Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 28 Brazil Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 29 Mexico Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 30 Rest of Latin America Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 31 GCC Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 32 Africa Stroke Management Market (US$ Million), 2021 - 2031
  • FIG. 33 Rest of Middle East and Africa Stroke Management Market (US$ Million), 2021 - 2031